On June 2, 2023, we were honored to host a pre-ASCO Symposium where we brought together patients, practitioners, and experts in life sciences, digital health, policy, and advocacy to delve into the transformative power of generative AI in the delivery of cancer care.
See highlights from the Symposium below.
Want to see more? You can!
In the age of AI, oncologists now have an opportunity to leverage patient-reported outcomes and real-world data to drive guideline-concordant care. Join us as we explore AI’s role in supporting physician decision-making and its ability to, in turn, better serve patients.
Join us as our panel of experts and patient advocates discusses the role of AI & digital health solutions in equitable clinical trial recruitment and examine how AI-driven patient empowerment and self-advocacy can contribute to clinical-trial matching.
Explore how opt-in AI can empower patients with personalized, relevant information, and how this approach coupled with true patient ownership of their medical records will both support the pharmaceutical industry’s commercial goals but also better serve patients.
Maya R. Said, ScD
Founder & CEO, Outcomes4Me
Sunil Verma, MD
Senior VP, Global Head of Oncology, Medical, AstraZeneca
Aradhana Ghosh, MD
VP, Oncology Informatics,
Arun Krishna, PhD
VP, Head of US Lung Cancer Business, AstraZeneca
Crystal S. Denlinger, MD, FACP
Senior VP, Chief Scientific Officer, NCCN©
V.K. Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Founder, Black Cancer Collaborative, Breast & Ovarian Cancer Survivor
Prasanth Reddy, MD, MPH, FACP
Senior VP & Global Head of Enterprise Oncology, Labcorp
Debra Friedman, MD, MS
Director, Pediatric Hematology & Oncology, Vanderbilt-Ingram Cancer Center
Steven Isakoff, MD, PhD
Associate Director, Clinical Research, Mass General Cancer Center
Chadi Nabhan, MD, MBA, FACP
Senior VP & Chairman, Caris Precision Oncology Alliance
Chief Patient Officer,
Grace Cordovano, PhD, BCPA
Founder, Enlightening Results
Director of Marketing & Community, Outcomes4Me, Breast Cancer Survivor
Kyle Holen, MD
SVP Head of Development, Therapeutics and Oncology, Moderna